A gene therapy study developed by Dr Amit Nathwani (UCL Cancer Institute) and colleagues in collaboration with St. Jude Children's Research Hospital, Memphis, Tennessee, has shown that adults with haemophilia B benefit from the treatment, reducing need for injections with clotting factor to prevent bleeds. The findings of the six-person study mark the first evidence that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder.
Further information:
Downloadable audio podcast: http://bit.ly/tpgZ4e
BBC News: http://bit.ly/sMPUHn
New York Times: http://bit.ly/twldkJ
UCL press release: http://bit.ly/v5xtmE
UCL is consistently ranked as one of the world's very best universities. As a multi-faculty, research-intensive university in central London, our research helps tackle global challenges and feeds directly into outstanding degree programmes. Visit us at www.ucl.ac.uk
Would hemophiliacs who develop inhibitor be able to benefit from this treatment?
OlivierVid73 1 month ago
@OlivierVid73 - As only the producer of the video, I'm sorry that I can't answer your question. But if you want to read more, click on the link under the video to the UCL press release; that has a link to the original article in the New England Journal of Medicine, where this research was published. Good luck! I hope you find the answer. Rob
UCLTV 1 month ago
What about Haemophilia A - Factor VIII deficiency, can this treatment be applied to it in the same way?
Starsgoalie 2 months ago
@Starsgoalie - At the moment, no. Scientists do hope to apply this same method of gene therapy in the very near future to Haemophilia A, as well as diabetes and liver cancer.
UCLTV 2 months ago